Characterisation of the Novel HLA‐DRB3*02:240 Allele by Sequencing‐Based Typing
HLA · 2026-09 · 108 (3)
DOI: 10.1111/tan.70963 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, online erschienen am 03.09.2026. Verfasst von Intissar Dalhoumi und 4 weiteren Autor:innen. Beteiligte Einrichtung: CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France. Hauptthemen laut MEDLINE: Alleles, Exons, HLA-DRB3 Chains, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 3 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
HLA‐DRB3*02:240 differs from HLA‐DRB3*02:20 by one nucleotide substitution in codon 74 in exon 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.
- Laboratorio d'Immunogenetica dei Trapianti, IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Italy.
- Bordeaux University, CNRS, INSERM, ImmunoConcEpt, UMR 5164, ERL 1303, Bordeaux, France.
ORCID-Profile: Intissar Dalhoumi, Marco Andreani, Marine Cargou, Gwendaline Guidicelli, Jonathan Visentin
Zitieren
APA
Dalhoumi, I., Andreani, M., Cargou, M., Guidicelli, G., & Visentin, J. (2026). Characterisation of the Novel HLA‐DRB3*02:240 Allele by Sequencing‐Based Typing. HLA, 108(3). https://doi.org/10.1111/tan.70963
Vancouver
Dalhoumi I, Andreani M, Cargou M, Guidicelli G, Visentin J. Characterisation of the Novel HLA‐DRB3*02:240 Allele by Sequencing‐Based Typing. HLA. 2026;108(3). doi:10.1111/tan.70963
BibTeX
@article{Dalhoumi2026,
author = {Dalhoumi, Intissar and Andreani, Marco and Cargou, Marine and Guidicelli, Gwendaline and Visentin, Jonathan},
title = {Characterisation of the Novel HLA‐DRB3*02:240 Allele by Sequencing‐Based Typing},
journal = {HLA},
year = {2026},
volume = {108},
number = {3},
doi = {10.1111/tan.70963}
}
EUVIMED